Reconstituted human polyclonal plasma-derived secretory-like IgM and IgA maintain the barrier function of epithelial cells infected with an enteropathogen

Journal of Biological Chemistry

Volumn 289, Issue 31, 2014, Pages 21617-21626

  Longet, Stéphanie ^a   Vonarburg, Cédric ^b   Lötscher, Marius ^b   Miescher, Sylvia ^b   Zuercher, Adrian ^b   Corthésy, Blaise ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b CSL Behring AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; MONOCLONAL ANTIBODIES;

AUTOIMMUNE CONDITIONS; BARRIER FUNCTIONS; EPITHELIAL CACO-2 CELLS; EPITHELIAL CELLS; INTRAVENOUS ADMINISTRATION; PROINFLAMMATORY CYTOKINES; PROTECTIVE FUNCTION; SHIGELLA FLEXNERI;

CELLS;

IMMUNOGLOBULIN M; INTERLEUKIN 8; IPAB PROTEIN; IPAC PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; SECRETORY IMMUNOGLOBULIN; SECRETORY IMMUNOGLOBULIN M; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN A;

ARTICLE; BACTERIAL LOAD; BACTERIAL NEUTRALIZATION; BACTERIAL VIRULENCE; CACO 2 CELL LINE; CELL AGGLUTINATION; CELL AGGREGATION; CELL FUNCTION; CELL INTEGRITY; CONTROLLED STUDY; ELECTRIC RESISTANCE; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL PROCEDURES; IN VITRO STUDY; INFECTED CELL; INFLAMMATION; INTERNALIZATION; INTESTINE EPITHELIUM CELL; MEMBRANE RECONSTITUTION; MOLECULAR BIOLOGY; MONOLAYER CULTURE; NONHUMAN; PLASMID; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; SHIGELLA FLEXNERI; SHIGELLOSIS; TRANSPITHELIAL ELECTRIC RESISTANCE; BACTERIAL COUNT; BLOOD; CONFOCAL MICROSCOPY; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; SECRETION (PROCESS); VIRULENCE;

CACO-2 CELLS; CHEMOKINES; COLONY COUNT, MICROBIAL; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; HOMEOSTASIS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; MICROSCOPY, CONFOCAL; SHIGELLA FLEXNERI; VIRULENCE;

EID: 84905403645     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.549139     Document Type: Article

References (52)

1. Brandtzaeg, P., and Prydz, H. (1984) Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins. Nature 311, 71-73 (Pubitemid 14065284)
2. Klimovich, V. B. (2011) IgM and its receptors: structural and functional aspects. Biochemistry 76, 534-549
3. Corthésy, B. (2013) Multi-faceted functions of secretory IgA at mucosal surfaces. Front. Immunol. 10.3389/fimmu.2013.00185
4. Brandtzaeg, P. (2013) Secretory IgA: designed for anti-microbial defense. Front. Immunol. 10.3389/fimmu.2013.00222
5. Gronwall, C., Vas, J., and Silverman, G. J. (2012) Protective roles of natural IgM antibodies. Front. Immunol. 10.3389/fimmu.2012.00066
6. Croft, N. M., and Hodges, M. (2005) IgM: mucosal response in acute diarrhoeal disease of infants. Scand. J. Gastroenterol. 40, 965-971 (Pubitemid 41117022)
7. Brandtzaeg, P., Karlsson, G., Hansson, G., Petruson, B., Björkander, J., and Hanson, L. A. (1987) The clinical condition of IgA-deficient patients is related to the proportion of IgD- and IgM-producing cells in their nasal mucosa. Clin. Exp. Immunol. 67, 626-636 (Pubitemid 17031806)
8. Baumgarth, N., Herman, O. C., Jager, G. C., Brown, L. E., Herzenberg, L. A., and Chen, J. (2000) B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 192, 271-280 (Pubitemid 30470309)
9. Diamond, M. S., Sitati, E. M., Friend, L. D., Higgs, S., Shrestha, B., and Engle, M. (2003) A critical role for induced IgM in the protection against West Nile virus infection. J. Exp. Med. 198, 1853-1862 (Pubitemid 38032118)
10. Seiler, P., Kalinke, U., Rülicke, T., Bucher, E. M., Böse, C., Zinkernagel, R. M., and Hengartner, H. (1998) Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic mice. J. Virol. 72, 2253-2258 (Pubitemid 28100783)
11. Boes, M., Prodeus, A. P., Schmidt, T., Carroll, M. C., and Chen, J. (1998) A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med. 188, 2381-2386 (Pubitemid 29028511)
12. Salinas-Carmona, M. C., and Pérez-Rivera, I. (2004) Humoral immunity through immunoglobulin M protects mice from an experimental actinomycetoma infection by Nocardia brasiliensis. Infect. Immun. 72, 5597-5604 (Pubitemid 39303667)
13. Alugupalli, K. R., Gerstein, R. M., Chen, J., Szomolanyi-Tsuda, E., Woodland, R. T., and Leong, J. M. (2003) The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J. Immunol. 170, 3819-3827 (Pubitemid 36359252)
14. Subramaniam, K. S., Datta, K., Quintero, E., Manix, C., Marks, M. S., and Pirofski, L. A. (2010) The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J. Immunol. 184, 5755-5767
15. Couper, K. N., Roberts, C. W., Brombacher, F., Alexander, J., and Johnson, L. L. (2005) Toxoplasma gondii-specific immunoglobulin M limits parasite dissemination by preventing host cell invasion. Infect. Immun. 73, 8060-8068 (Pubitemid 41740293)
16. Konishi, E., and Nakao, M. (1992) Naturally occurring immunoglobulin M antibodies: enhancement of phagocytic and microbicidal activities of human neutrophils against Toxoplasma gondii. Parasitology 104, 427-432
17. Baral, T. N., De Baetselier, P., Brombacher, F., and Magez, S. (2007) Control of Trypanosoma evansi infection is IgM mediated and does not require a type I inflammatory response. J. Infect. Dis. 195, 1513-1520 (Pubitemid 46717470)
18. Ehrenstein, M. R., O'Keefe, T. L., Davies, S. L., and Neuberger, M. S. (1998) Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc. Natl. Acad. Sci. U.S.A. 95, 10089-10093 (Pubitemid 28415299)
19. Boes, M., Esau, C., Fischer, M. B., Schmidt, T., Carroll, M., and Chen, J. (1998) Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 160, 4776-4787 (Pubitemid 28215311)
20. Orange, J. S., Hossny, E. M., Weiler, C. R., Ballow, M., Berger, M., Bonilla, F. A., Buckley, R., Chinen, J., El-Gamal, Y., Mazer, B. D., Nelson, R. P., Jr., Patel, D. D., Secord, E., Sorensen, R. U., Wasserman, R. L., Cunningham-Rundles, C., Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology (2006) Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J. Allergy. Clin. Immunol. 117, S525-S553
21. Durandy, A., Kaveri, S. V., Kuijpers, T. W., Basta, M., Miescher, S., Ravetch, J. V., and Rieben, R. (2009) Intravenous immunoglobulins: understanding properties and mechanisms. Clin. Exp. Immunol. 158, 2-13
22. Schedel, I., Dreikhausen, U., Nentwig, B., Höckenschnieder, M., Rauthmann, D., Balikcioglu, S., Coldewey, R., and Deicher, H. (1991) Treatment of Gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial. Crit. Care Med. 19, 1104-1113
23. Behre, G., Schedel, I., Nentwig, B., Wörmann, B., Essink, M., and Hiddemann, W. (1992) Endotoxin concentration in neutropenic patients with suspected Gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins. Antimicrob. Agents Chemother. 36, 2139-2146
24. Norrby-Teglund, A., Haque, K. N., and Hammarström, L. (2006) Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis. J. Intern. Med. 260, 509-516 (Pubitemid 44772370)
25. Lachmann, R. A., van Kaam, A. H., Haitsma, J. J., Verbrugge, S. J., Delreu, F., and Lachmann, B. (2004) Immunoglobulin M-enriched intravenous polyclonal immunoglobulins reduce bacteremia following Klebsiella pneumoniae infection in an acute respiratory distress syndrome rat model. Exp. Lung Res. 30, 251-260 (Pubitemid 38716522)
26. Stehr, S. N., Knels, L., Weissflog, C., Schober, J., Haufe, D., Lupp, A., Koch, T., and Heller, A. R. (2008) Effects of IGM-enriched solution on polymorphonuclear neutrophil function, bacterial clearance, and lung histology in endotoxemia. Shock 29, 167-172
27. Racine, R., McLaughlin, M., Jones, D. D., Wittmer, S. T., MacNamara, K. C., Woodland, D. L., and Winslow, G. M. (2011) IgM production by bone marrow plasmablasts contributes to long-term protection against intracellular bacterial infection. J. Immunol. 186, 1011-1021
28. Mueller, M., Loh, M. Q., Tscheliessnig, R., Tee, D. H., Tan, E., Bardor, M., and Jungbauer, A. (2013) Liquid formulations for stabilizing IgMs during physical stress and long-term storage. Pharm. Res. 30, 735-750
29. Longet, S., Miled, S., Lötscher, M., Miescher, S. M., Zuercher, A. W., and Corthésy, B. (2013) Human plasma-derived polymeric IgA and IgM antibodies associate with secretory component to yield biologically active se-cretory- like antibodies. J. Biol. Chem. 288, 4085-4094
30. Cramer, M., Frei, R., Sebald, A., Mazzoletti, P., and Maeder, W. (2009) Stability over 36 months of a new liquid 10% polyclonal immunoglobulin product (IgPro10, Privigen) stabilized with L-proline. Vox Sang. 96, 219-225
31. Mathias, A., Longet, S., and Corthésy, B. (2013) Agglutinating secretory IgA preserves intestinal epithelial cell integrity during apical infection by Shigella flexneri. Infect. Immun. 81, 3027-3034
32. Favre, L. I., Spertini, F., and Corthésy, B. (2003) Simplified procedure to recover recombinant antigenized secretory IgA to be used as a vaccine vector. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 786, 143-151 (Pubitemid 36324570)
33. Phalipon, A., Cardona, A., Kraehenbuhl, J. P., Edelman, L., Sansonetti, P. J., and Corthésy, B. (2002) Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity 17, 107-115 (Pubitemid 34874623)
34. Cottet, S., Corthésy-Theulaz, I., Spertini, F., and Corthésy, B. (2002) Microaerophilic conditions permit to mimic in vitro events occurring during in vivo Helicobacter pylori infection and to identify Rho/Ras-associated proteins in cellular signaling. J. Biol. Chem. 277, 33978-33986
35. Rathman, M., Jouirhi, N., Allaoui, A., Sansonetti, P., Parsot, C., and Tran Van Nhieu, G. (2000) The development of a FACS-based strategy for the isolation of Shigella flexneri mutants that are deficient in intercellular spread. Mol. Microbiol. 35, 974-990 (Pubitemid 30137769)
36. Bahrani, F. K., Sansonetti, P. J., and Parsot, C. (1997) Secretion of Ipa proteins by Shigella flexneri: inducer molecules and kinetics of activation. Infect. Immun. 65, 4005-4010 (Pubitemid 27422050)
37. Forbes, S. J., Bumpus, T., McCarthy, E. A., Corthésy, B., and Mantis, N. J. (2011) Transient suppression of Shigella flexneri type 3 secretion by a protective O-antigen-specific monoclonal IgA. MBio 10.1128/mBio.00042-11
38. Zurawski, D. V., Mitsuhata, C., Mumy, K. L., McCormick, B. A., and Maurelli, A. T. (2006) OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence. Infect. Immun. 74, 5964-5976 (Pubitemid 44484584)
39. Renegar, K. B., Small, P. A. Jr., Boykins, L. G., and Wright, P. F. (2004) Effects of short-term sleep deprivation on murine immunity to influenza virus in young adult and senescent mice. J. Immunol. 173, 1978-1986
40. Stubbe, H., Berdoz, J., Kraehenbuhl, J. P., and Corthésy, B. (2000) Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers. J. Immunol. 164, 1952-1960 (Pubitemid 30108750)
41. Yang, J. Y., Lee, S. N., Chang, S. Y., Ko, H. J., Ryu, S., and Kweon, M. N. (2014) A mouse model of shigellosis by intraperitoneal infection. J. Infect. Dis. 209, 203-215
42. Fiorentino, M., Levine, M. M., Sztein, M. B., and Fasano, A. (2014) Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal function, antigen trafficking, and cytokine release. PLoS ONE 10.1371/journal.pone.0085211
43. Blander, J. M., and Sander, L. E. (2012) Beyond pattern recognition: five immune checkpoints for scaling the microbial threat. Nat. Rev. Immunol. 12, 215-225
44. Perrier, C., Sprenger, N., and Corthésy, B. (2006) Glycans on secretory component participate in innate protection against mucosal pathogens. J. Biol. Chem. 281, 14280-14287 (Pubitemid 43848356)
45. Clerc, P., and Sansonetti, P. J. (1987) Entry of Shigella flexneri into HeLa cells: evidence for directed phagocytosis involving actin polymerization and myosin accumulation. Infect. Immun. 55, 2681-2688 (Pubitemid 17154508)
46. Watarai, M., Funato, S., and Sasakawa, C. (1996) Interaction of Ipa proteins of Shigella flexneri with α5β1 integrin promotes entry of the bacteriainto mammalian cells. J. Exp. Med. 183, 991-999 (Pubitemid 26114799)
47. Norrby-Teglund, A., Ihendyane, N., Kansal, R., Basma, H., Kotb, M., Andersson, J., and Hammarström, L. (2000) Relative neutralizing activity in polyspecific IgM, IgA, and IgG preparations against groupAstreptococcal superantigens. Clin. Infect. Dis. 31, 1175-1182 (Pubitemid 32295447)
48. Berstad, A. E., and Brandtzaeg, P. (1998) Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract. Gut 42, 522-529 (Pubitemid 28186570)
49. Lampert, I. A., Schofield, J. B., Amlot, P., and Van Noorden, S. (1993) Protection of germinal centres from complement attack: decay-accelerating factor (DAF) is a constitutive protein on follicular dendritic cells: a study in reactive and neoplastic follicles. J. Pathol. 170, 115-120 (Pubitemid 23192362)
50. Singh, K., Chang, C., and Gershwin, M. E. (2014) IgA deficiency and autoimmunity. Autoimmun. Rev. 13, 163-177
51. Rol, N., Favre, L., Benyacoub, J., and Corthésy, B. (2012) The role of secretory immunoglobulin A in the natural sensing of commensal bacteria by mouse Peyer's patch dendritic cells. J. Biol. Chem. 287, 40074-40082
52. Mestecky, J., and Russell, M. W. (2009) Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of SIgA at mucosal surfaces. Immunol. Lett. 124, 57-62